Financials Oxford Cannabinoid Technologies Holdings Plc
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.15 GBX | -3.23% | -56.52% | -76.00% |
05-08 | Oxford Cannabinoid shares plummet following delisting request | AN |
05-08 | Oxford Cannabinoid Technologies Files for Delisting From London Bourse | MT |
Valuation
Fiscal Period: April | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 11.28 | 13.73 | 1.633 | - |
Enterprise Value (EV) 1 | 11.28 | 11.44 | 0.4476 | 3.661 |
P/E ratio | -2.39 x | - | -0.68 x | -0.52 x |
Yield | - | - | - | - |
Capitalization / Revenue | - | - | - | - |
EV / Revenue | - | - | - | - |
EV / EBITDA | - | -1.65 x | -0.13 x | -0.92 x |
EV / FCF | - | - | - | - |
FCF Yield | - | - | - | - |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 960,416 | 960,416 | 1,088,416 | - |
Reference price 2 | 0.0118 | 0.0143 | 0.001500 | 0.001500 |
Announcement Date | 25/07/22 | 31/08/23 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: April | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net sales 1 | - | - | - | - |
EBITDA 1 | - | -6.935 | -3.438 | -3.984 |
EBIT 1 | - | -7.038 | -3.484 | -3.984 |
Operating Margin | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -7.034 | -3.475 | -3.978 |
Net income 1 | -4.712 | -5.945 | -2.2 | -3.153 |
Net margin | - | - | - | - |
EPS 2 | -0.004910 | - | -0.002200 | -0.002900 |
Free Cash Flow | - | - | - | - |
FCF margin | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share 2 | - | - | - | - |
Announcement Date | 25/07/22 | 31/08/23 | - | - |
Balance Sheet Analysis
Fiscal Period: April | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net Debt 1 | - | - | - | 2.03 |
Net Cash position 1 | - | 2.3 | 1.19 | - |
Leverage (Debt/EBITDA) | - | - | - | -0.509 x |
Free Cash Flow | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - |
Assets 1 | - | - | - | - |
Book Value Per Share | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Capex | - | - | - | - |
Capex / Sales | - | - | - | - |
Announcement Date | 25/07/22 | 31/08/23 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-76.00% | 2.04M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- OCTP Stock
- Financials Oxford Cannabinoid Technologies Holdings Plc